Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of the APD Treatment of Toddlers and Newborns With the Silencia PD Cycler

NCT07004907 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.

NCT NCT07004907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of the APD Treatment of Toddlers and Newborns With the Silencia PD Cycler
Lead sponsor
Fresenius Medical Care Deutschland GmbH
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
November 30, 2026
Enrollment
13 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure acute chronic